Literature DB >> 6105477

Tonsillectomy and childhood Hodgkin's disease.

N J Vianna, C E Lawrence, J N Davies, J Arbuckle, S Harris, W Marani, J Wilkinson.   

Abstract

The relation between previous tonsillectomy and Hodgkin's disease was examined in a case-control study involving 81 histologically confirmed childhood cases and two sibling control groups. When cases were compared with age-matched sibling controls a significant association (p < 0.02), with a risk of 2.7, was observed for children who had undergone tonsillectomy. A significant association (p < 0.01), with a relative risk of 2.5, was also shown when all siblings were used for comparison. History of hospital admissions, age at tonsillectomy, Rye histological subtype, birth order, and sibship size did not appear to modify the effect of this operative procedure on the risk of Hodgkin's disease.

Entities:  

Mesh:

Year:  1980        PMID: 6105477     DOI: 10.1016/s0140-6736(80)90339-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  4 in total

1.  History of tonsillectomy and appendectomy in Hodgkin's disease.

Authors:  Z Gledovic; Z Radovanovic
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

2.  ABC of poisoning. Problems in children.

Authors:  J Henry; G Volans
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-25

3.  The Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC): past medical history in children with cancer.

Authors:  A L Hartley; J M Birch; P A McKinney; V Blair; M D Teare; J Carrette; J R Mann; C A Stiller; G J Draper; H E Johnston
Journal:  J Epidemiol Community Health       Date:  1988-09       Impact factor: 3.710

4.  The Inter-Regional Epidemiological Study of Childhood Cancer (IRESCO). Study design, control selection and data collection.

Authors:  J M Birch; J R Mann; R A Cartwright; G J Draper; J A Waterhouse; A L Hartley; H E Johnston; P A McKinney; C A Stiller; P A Hopton
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.